Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

NIH × B3(Fv)-PE38KDEL recombinant immunotoxin × 1 year × Clear all

Sponsor

Interventions

Specimen Handling 311 Magnetic Resonance Spectroscopy 219 Biopsy 195 Nivolumab 60 Cyclophosphamide 60 X-Rays 46 Carboplatin 46 pembrolizumab 45 Radiation 45 Immunoglobulin G 45 Disulfides 45 Paclitaxel 43 Taxes 42 Cisplatin 42 Doxorubicin 40 Platinum 38 1,2-diaminocyclohexaneplatinum II citrate 38 atezolizumab 37 Radiotherapy 36 Ipilimumab 31 Vincristine 30 Prednisone 30 Bevacizumab 30 olaparib 29 fludarabine 29 Gemcitabine 29 CTLA-4 Antigen 28 Cytarabine 27 Rituximab 26 Phantoms, Imaging 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡